November 10, 2022 — A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
November 10, 2022
November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...
November 08, 2022
November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...
November 07, 2022Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...
November 05, 2022
October 31, 2022 — Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 ...
October 31, 2022
October 26, 2022 — A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute ...
October 26, 2022Sponsored Content
Blog
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
November 13, 2023
October 25, 2022 — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms ...
October 25, 2022
October 20, 2022 — A team of Case Western Reserve University scientists has received a four-year, $3.7 million National ...
October 20, 2022
October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...
October 14, 2022Sponsored Content
Blog
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
November 02, 2023
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's ...
October 13, 2022
September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...
September 15, 2022
September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of ...
September 14, 2022Sponsored Content
Blog | ECG
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 24, 2022
September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ...
September 13, 2022
September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...
September 09, 2022
September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the OCTARAY ...
September 08, 2022© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now